AVBP ArriVent BioPharma, Inc.
$29.00▲ +1.05%
Healthcare
Other
After hours
$29.00▲ +0.00%
Sep 11, 7:30 PM ET
Volume 1.13M
Avg Volume (10D) 401.7K
Key Metrics & Fundamentals
Market Cap
$1.43B
P/E Ratio
–
Div Yield
–%
52W Range
17.00 - 35.83
% vs 50 MA
-7.55%
% vs 200 MA
6.86%
RSI-14
39.9
MACD Histogram
-0.0500
Beta (1Y vs SPY)
1.28
Free Cash Flow
-$39.58M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$52.69M
COGS
–
Operating Exp
$52.69M
Operating Income
-$52.69M
EBIT
-$52.69M
Pretax Income
-$49.89M
Net Income
-$49.89M
EPS (Diluted)
-1.05
Price & Volume History
Loading chart…
Recent News
ArriVent BioPharma Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 12, 2026 8:01 PM
EGFR Inhibitors Market to Witness Upsurge in Growth at a CAGR of 7.9% During the Forecast Period (2026-2036) Owing to the Entry of Next-generation TKIs, ADCs, and Combination Strategies with Immunotherapy| DelveInsight
PR Newswire · Jun 15, 2026 4:31 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See AVBP's money flow as a full page
Social Sentiment
No Reddit posts found for AVBP.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.